The Man Studying Your Blood Sugar #686

The Man Studying Your Blood Sugar #686

From Biohacking News by Zestology by Tony Wrighton

April 2, 2026 · 6 min · Episode 688

About this episode

Sharam Fouladgar-Mercer discusses the impact of running Signos and analyzing data from a large clinical trial on his personal health routine.

Biohackers have been using CGMs (Continuous Glucose Monitors) for years. Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared CGM for weight management. So how has running a company (and looking at all the data from their 35k person clinical trial) changed his own routine? Follow Sharam Fouladgar-Mercer on LinkedIn.

People in this episode

Host: Tony Wrighton

Guest: Sharam Fouladgar-Mercer

Topics covered

  • Continuous Glucose Monitors
  • weight management
  • biohacking
  • health data
  • clinical trials

Keywords

  • CGM
  • blood sugar
  • biohacking
  • health
  • nutrition
  • weight management
  • clinical trial

Mentioned in this episode

Organizations: Signos, FDA

More episodes of Biohacking News by Zestology

Explore listener stats, chart rankings, contacts and more on the Biohacking News by Zestology podcast page.